Polystyrene nanoplastics induced toxicity in human endothelial cells via atherogenic and autophagy pathways Authors: Banafsheh Yalameha, Cigir Biray Avci, Sara Aghakhani Chegeni, Farhad Rahmanifar, Asghar Khalilnezhad, Mahdi Mahdipour, Elham Shahriyari, Farhad Bani, Adel Feizi, Reza Rahbarghazi Published: 2026 ABSTRACT BackgroundPolystyrene nanoplastics (PS NPs) pollution poses an emerging threat to the ecosystem and human health owing to their physicochemical properties. Excessive exposure to PS NPs can disrupt the cardiovascular system, especially the function of endothelial cells (ECs). Given the potential pathological significance of particles, the present study aimed to investigate the cytotoxic effects of PS NPs on ECs in in vitro and ex ovo models, as well as their underlying mechanisms.MethodsPS NPs were characterized using DLS, SEM, and FTIR. Human umbilical vein ECs (HUVECs) were first treated with 5 and 100 µg/ml PS NPs for all in vitro assays. Cellular uptake of PS NPs was monitored by flow cytometry, and the interaction of PS NP-treated HUVECs with peripheral blood mononuclear cells was evaluated using surface plasmon resonance (SPR). Protein and cDNA adsorption onto PS NPs were analyzed by SDS-PAGE and agarose gel electrophoresis, respectively. A PCR array was also utilized for analyzing atherogenic and autophagy pathways. For ex ovo toxicity assessment, chicken embryos were exposed to 40 µg/ml PS NPs for 7 days. Then, the heart samples of embryos were investigated for PS NPs internalization and histopathological changes by DAPI and hematoxylin and eosin staining, respectively.ResultsPS NPs were taken up by HUVECs, especially at a 5 µg/ml dose. The protein corona formed on the surface of PS NPs, without being affected by cDNA. SPR analysis revealed that PS NPs altered the interaction of endothelial and immune cells. Exposure to PS NPs could induce changes in atherogenic and autophagy pathways in ECs. Histopathological analyses of chicken embryos indicated cardiac damage and the accumulation of PS NPs in cardiac tissue after 7 days of exposure.ConclusionTaken together, these findings indicated that PS NPs may dose-dependently induce endothelial dysfunction in ECs and histopathological damage in the cardiac tissue of chicken embryos. These toxic effects were likely mediated through affecting autophagy and atherosclerotic pathways, and the interaction of endothelial-immune cells. Therefore, the results emphasize the high potential for toxicity and cardiovascular risks associated with PS NPs. Introduction Cardiovascular diseases (CVDs) are one of the leading causes of human death worldwide, with high socioeconomic consequences [1, 2]. It has been indicated that several risk factors, such as high blood pressure, high cholesterol, diabetes, medications, and obesity, etc. are closely associated with the development and occurrence of CVDs [3]. Besides, exposure to hazardous chemicals, environmental pollutants, and toxic compounds such as microplastics (MPs) and nanoplastics (NPs) is an emerging cause of CVDs [4–6]. The low cost and ease of production of plastic-based polymers have led to their uncontrolled increase in different societies [7]. Regarding the destructive environmental properties, NPs and MPs can threaten human health, and several studies have been conducted in recent years to assess the possible detrimental effects of NPs and MPs on the cardiovascular system [8]. In general, plastic particles are human-made products, which decompose into nanoplastics (NPs; <100 nm) and microplastics (MPs; 100 nm–5 mm) [7]. Due to their small size, MPs and NPs can accumulate in freshwater, soil, and air systems and can enter the human body through the food chain, respiratory system, or even the skin barrier [9]. The negative effects of NPs, including intestinal toxicity, neurotoxicity, etc., have often been attributed to polystyrenes (PS) [10]. PS is extensively applied in food packaging, consumer products, insulation materials, and electronic appliances [11]. Its resistance to degradation allows PS to remain for a long time in the environment and human exposure. The nanoscale size of PS NPs results in a high surface area-to-volume ratio, enhancing their potential to interact with biological molecules [12]. Data from various studies have confirmed that plastic particles can exacerbate the background pathological conditions related to the occurrence of CVDs [13, 14]. For instance, the activity of immune cells and production of proinflammatory cytokines (IL-1β, -6, -18, and TNF-α) increase in the presence of plastic particles, leading to the loss of endothelial cell (EC)-EC connection [15]. Inside inflamed ECs, the regulation of certain signaling pathways, such as JAK1/STAT3-TF, can lead to EC disintegration. The possibility of myocardial fibrosis and apoptotic changes is increased in the presence of plastic particles via the up-regulation of the Wnt/β-catenin signaling pathway, excessive oxidative stress, etc [13, 14]. Therefore, it seems that both NPs and MPs can exert pleiotropic effects on cardiovascular systems with a wide range of clinical symptoms such as irregular heartbeat and prominent cardiac fibrosis [14]. In the vascular lumen, plastic particles stimulate hemolysis and platelet activation, abnormal lipid metabolism, resulting in thrombosis [16]. Besides, the changes in gut microbiota following the ingestion of plastic particles can also increase the possibility of CVDs [14]. The degree of cardiotoxicity caused by plastic particles is related to the structural characteristics, such as surface, type, structure, and size of these substances, the dose, and exposure time [17]. Due to the existence of various plastic types, pollution, and pleotropic effects on biological systems, there is no comprehensive definition of plastic particles in the scientific literature and policymaking strategies. The identification of plastic particles, such as polymer type, functionality, surface characteristics, etc., can help to determine their detrimental impact on human health [18]. Since the relationship between NPs and CVDs has not been fully defined, the current study aims to investigate the cytotoxic effects of PS NPs on adult ECs in vitro and pathological conditions in chicken embryos. (Fig. 1) It seems that current data can help in understanding the molecular mechanisms related to PS in biological systems. Fig. 1Schematic illustration of the present study. Created by online biorender software. 2026 Schematic illustration of the present study. Created by online biorender software. 2026 Materials and methods Chemicals and reagents Fluorescent-PS NPs were provided by the Institute for Color Science and Technology (ICST), Tehran, Iran. Easy cDNA Supra-TM synthesis kit (Cat. No. A101161; Parstous, Iran), Ficoll-Paque solution (Cat. No. 17-0840-02; Pharmacia Biotech AB, Sweden), Trizol reagent (Cat. No. YT9066; Yekta Tajhiz Azma, Iran), MTT powder (Cat. No. M5655; Sigma-Aldrich, USA), Fetal bovine serum (FBS; Cat. No. FB-1001/100; Biosera, South America), penicillin-streptomycin (Pen-Strep; Cat. No. XC-A4122; Biosera, France), DMEM/F12 (Cat. No. 32500-035; Gibco, USA), and 0.25% Trypsin-EDTA solution (Cat. No. BI-1602; BIO-IDEA, Iran) were obtained from mentioned companies. Characterization of PS NPs Scanning electron microscopy (SEM) In the current study, PS NPs were synthesized by Dr. Behzad Shirkavand Hadavand via suspension polymerization. Briefly, the purification of styrene involved washing with NaOH, rinsing with water, and distilling under vacuum. Under a nitrogen atmosphere, suspension polymerization was carried out using benzoyl peroxide (1–3% w/v) as an initiator and polyvinyl alcohol (1% w/v) as a stabilizer. To synthesize PS NPs, styrene droplets were gradually added at 90 °C and stirred for 30 min. After 8 h of polymerization, PS NPs were fluorescently labelled with Rhodamine B [19, 20]. The rhodamine B-labeled PS-NPs (Iran) were diluted to 40 mg/ml in phosphate-buffered saline (PBS). The actual size and morphologies of the PS were confirmed by SEM (Model: Mira-3 FEG SEM microscope, Tescan Co., Czech). Fourier transform infrared (FTIR) and dynamic light scattering (DLS) FTIR spectroscopy (TENSOR 27, Germany) was used to analyze the composition of the particles. Furthermore, the size and zeta potential values of PS NPs were measured using DLS (Anton Paar Litesizer 500, Austria). Of note, DLS was analyzed by selecting particles from the DLS library dispersed in deionized water at 25 °C. Cell culture Human umbilical vein ECs (HUVECs; National Cell Bank of Iran) were cultured in DMEM/F12 supplemented with 10% FBS and 1% Pen-Strep under standard conditions. Cultured cells were passaged using 0.25% Trypsin-EDTA and subjected to different analyses at passages 3 to 6. Cell viability assay To find the dose-dependent cytotoxic effects of PS on HUVECs, a conventional MTT assay was done. In brief, 1.0 × 104 HUVECs were plated in each well of 96-well plates and allowed the cells to reach 70–80% confluence. After that, HUVECs were treated with 5, 10, 20, 50, 100, 200, and 400 µg/ml of PS NPs for 48 h. The procedure was continued with supernatant removal followed by the addition of 200 µl MTT (0.5 mg/ml) solution and maintaining plates at 37 °C for 3 h. In the next step, the supernatants were removed and replaced with 100 µl dimethyl sulfoxide. The ODs were read at 570 nm wavelength using a microplate reader (BioTek, USA), and values were expressed as % of control HUVECs. Based on the MTT data, 5 µg/ml and 100 µg/ml PS NPs were used for subsequent analyses. Monitoring PS NPs uptake into HUVECs The uptake rates were monitored in PS NP-treated HUVECs using flow cytometry analysis. At first, HUVECs were seeded into 6-well plates at an initial density of 5 × 105 cells/well and allowed to attach overnight. After incubation of HUVECs with 5 µg/ml and 100 µg/ml PS NPs for 48 h, the cells were detached and washed twice with PBS to eliminate unbound particles, and fixed with 4% paraformaldehyde (PFA) for 20 min at 4 °C. After removing PFA and washing with PBS, HUVECs were resuspended in 500 µl PBS and analyzed using a BD FACSCalibur™ flow cytometer and FlowJo software version 10.6.1. PCR array analysis The expression of genes related to atherogenic and autophagy pathways was determined using a PCR array analysis. First, the total RNA of HUVECs was isolated using the Trizol reagent, and the samples’ purity was assessed by a NanoDrop UV-Vis Spectrophotometer (Thermo Fisher Scientific; Waltham, MA). The isolated RNAs were reverse-transcribed into cDNA using the Easy cDNA Supra-TM synthesis kit, and the expression of genes was measured by autophagy (Table 1) and atherogenic (Table 2) genes using the Light Cycler 480 instrument II (Roche). Data were analyzed using the 2−ΔΔCT method to compute relative gene expression, and the results were expressed as log2(fold change). Values greater and less than 2 (± 2) and p-values < 0.05 were regarded as differentially expressed. Table 1The sequence of primers used for monitoring the autophagy pathwayGeneForward primerReverse primerTmAMBRA15′-CTCTTCCTCAGACAACCAGGGT-3′5′-TCCAAGCGAAGGTGCAGACATC-3′63.13ATG16L15′-CTACGGAAGAGAACCAGGPAGCT-3′5′-CTGGTAGAGGTTCCTTTGCTGC-3′61.2ATG55′-GCAGATGGACAGTTGCACACAC-3′5′-GAGGTGTTTCCAACATTGGCTCA-3′61.56ATG9A5′-GCTTCCTCAAGGAGCAGGTTCA-3′5′-CCACATTTGCGATAAGGCTCAGG-3′62.09BAD5′-CCAACCTCTGGGCAGCACAGC-3′5′-TTTGCCGCATCTGCGTTGCTGT-3′66.59BAX5′-TCAGGATGCGTCCACCAAGAAG-3′5′-TGTGTCCACGGCGGCAATCATC-3′62.57BCL25′-ATCGCCCTGTGGATGACTGAGT-3′5′-GCCAGGAGAAATCAAACAGAGGC-3′61.98BCL2L15′-GCCACTTACCTGAATGACCACC-3′5′-AACCAGCGGTTGAAGCGTTCCT-3′65.22BECN15′-CTGGACACTCAGCTCAACGTCA-3′5′-CTCTAGTGCCAGCTCCTTTAGC-3′60.48CASP85′-AGAAGAGGGTCATCCTGGGAGA-3′5′-TCAGGACTTCCTTCAAGGCTGC-3′62.52CLN35′-GAACACTTCCCTGAGTCACGCT-3′5′-AGGTGAAACGGATGCGACAGCA-3′65CTSB5′-GCTTCGATGCACGGGAACAATG-3′5′-CATTGGTGTGGATGCAGATCCG-3′61.89CTSD5′-GCAAACTGCTGGACATCGCTTG-3′5′-GCCATAGTGGATGTCAAACGAGG-3′61.54DRAM25′-CCTTTCCTACCAAATGCAGCCC-3′5′-GCCACTGTGCAAAACTGATGAGC-3′63.23EIF4G15′-GCCATTTCAGAGCCCAACTTCTC-3′5′-CGGAAGTTCACAGTCACTGTTGG-3′61.83GABARAP5′-ATCTCCGAGCTGAGGATGCCTT-3′5′-GACACTTTCGTCACTGTAGGCAA-3′61.04GABARAPL15′-TTGTAGAGAAGGCTCCAAAAGCC-3′5′-GGTCTCAGGTGGATTCTCTTCC-3′59.83HGS5′-GACAGACTCTCAGCCCATTCCT-3′5′-TCATGCGGTTCACGAAGGTGGT-3′64.71HSPA85′-TCCTACCAAGCAGACACAGACC-3′5′-CAGGAGGTATGCCTGTGAGTTC-3′60.42HTT5′-CTCTGGTGTCAGATACTGCTGC-3′5′-CTCCTCTTCTCCAGACATCTGG-3′59.31MAPK145′-GAGCGTTACCAGAACCTGTCTC-3′5′-AGTAACCGCAGTTCTCTGTAGGT-3′61.07MAPK85′-GACGCCTTATGTAGTGACTCGC-3′5′-TCCTGGAAAGAGGATTTTGTGGC-3′61.07PIK3CG5′-GAGAGCTTGGAGGACGATGATG-3′5′-CCACGCTTCAGCAGAAATCTGG-3′62.07PIK3R45′-GATCCTGCCATAGCACAGCTTC-3′5′-CATGAAGATGGCTCTGGTCCAC-3′61.00RB15′-CAGAAGGTCTGCCAACACCAAC-3′5′-TTGAGCACACGGTCGCTGTTAC-3′63.58RPSGKB15′-TATTGGCAGCCCACGAACACCT-3′5′-GTCACATCCATCTGCTCTATGCC-3′61.11SQSTM15′-TGTGTAGCGTCTGCGAGGGAAA-3′5′-AGTGTCCGTGTTTCACCTTCCG-3′62.99TGM25′-TGTGGCACCAAGTACCTGCTCA-3′5′-GCACCTTGATGAGGTTGGACTC-3′61.2 Table 1The sequence of primers used for monitoring the autophagy pathwayGeneForward primerReverse primerTmAMBRA15′-CTCTTCCTCAGACAACCAGGGT-3′5′-TCCAAGCGAAGGTGCAGACATC-3′63.13ATG16L15′-CTACGGAAGAGAACCAGGPAGCT-3′5′-CTGGTAGAGGTTCCTTTGCTGC-3′61.2ATG55′-GCAGATGGACAGTTGCACACAC-3′5′-GAGGTGTTTCCAACATTGGCTCA-3′61.56ATG9A5′-GCTTCCTCAAGGAGCAGGTTCA-3′5′-CCACATTTGCGATAAGGCTCAGG-3′62.09BAD5′-CCAACCTCTGGGCAGCACAGC-3′5′-TTTGCCGCATCTGCGTTGCTGT-3′66.59BAX5′-TCAGGATGCGTCCACCAAGAAG-3′5′-TGTGTCCACGGCGGCAATCATC-3′62.57BCL25′-ATCGCCCTGTGGATGACTGAGT-3′5′-GCCAGGAGAAATCAAACAGAGGC-3′61.98BCL2L15′-GCCACTTACCTGAATGACCACC-3′5′-AACCAGCGGTTGAAGCGTTCCT-3′65.22BECN15′-CTGGACACTCAGCTCAACGTCA-3′5′-CTCTAGTGCCAGCTCCTTTAGC-3′60.48CASP85′-AGAAGAGGGTCATCCTGGGAGA-3′5′-TCAGGACTTCCTTCAAGGCTGC-3′62.52CLN35′-GAACACTTCCCTGAGTCACGCT-3′5′-AGGTGAAACGGATGCGACAGCA-3′65CTSB5′-GCTTCGATGCACGGGAACAATG-3′5′-CATTGGTGTGGATGCAGATCCG-3′61.89CTSD5′-GCAAACTGCTGGACATCGCTTG-3′5′-GCCATAGTGGATGTCAAACGAGG-3′61.54DRAM25′-CCTTTCCTACCAAATGCAGCCC-3′5′-GCCACTGTGCAAAACTGATGAGC-3′63.23EIF4G15′-GCCATTTCAGAGCCCAACTTCTC-3′5′-CGGAAGTTCACAGTCACTGTTGG-3′61.83GABARAP5′-ATCTCCGAGCTGAGGATGCCTT-3′5′-GACACTTTCGTCACTGTAGGCAA-3′61.04GABARAPL15′-TTGTAGAGAAGGCTCCAAAAGCC-3′5′-GGTCTCAGGTGGATTCTCTTCC-3′59.83HGS5′-GACAGACTCTCAGCCCATTCCT-3′5′-TCATGCGGTTCACGAAGGTGGT-3′64.71HSPA85′-TCCTACCAAGCAGACACAGACC-3′5′-CAGGAGGTATGCCTGTGAGTTC-3′60.42HTT5′-CTCTGGTGTCAGATACTGCTGC-3′5′-CTCCTCTTCTCCAGACATCTGG-3′59.31MAPK145′-GAGCGTTACCAGAACCTGTCTC-3′5′-AGTAACCGCAGTTCTCTGTAGGT-3′61.07MAPK85′-GACGCCTTATGTAGTGACTCGC-3′5′-TCCTGGAAAGAGGATTTTGTGGC-3′61.07PIK3CG5′-GAGAGCTTGGAGGACGATGATG-3′5′-CCACGCTTCAGCAGAAATCTGG-3′62.07PIK3R45′-GATCCTGCCATAGCACAGCTTC-3′5′-CATGAAGATGGCTCTGGTCCAC-3′61.00RB15′-CAGAAGGTCTGCCAACACCAAC-3′5′-TTGAGCACACGGTCGCTGTTAC-3′63.58RPSGKB15′-TATTGGCAGCCCACGAACACCT-3′5′-GTCACATCCATCTGCTCTATGCC-3′61.11SQSTM15′-TGTGTAGCGTCTGCGAGGGAAA-3′5′-AGTGTCCGTGTTTCACCTTCCG-3′62.99TGM25′-TGTGGCACCAAGTACCTGCTCA-3′5′-GCACCTTGATGAGGTTGGACTC-3′61.2 The sequence of primers used for monitoring the autophagy pathway Table 2The sequence of primers used for monitoring the atherosclerosis pathwayGeneForward primerReverse primerTmAPOA15′-GTGGATGTGCTCAAAGACAGCG-3′5′-GCTTGCTGAAGGTGGAGGTCAC-3′63.64APOB5′-AGAGGACAGAGCCTTGGTGGAT-3′5′-CTGGACAAGGTCATACTCTGCC-3′60.42APOE5′-GGGTCGCTTTTGGGATTACCTG-3′5′-CAACTCCTTCATGGTCTCGTCC-3′60.68BIRC35′-GCTTTTGCTGTGATGGTGGACTC-3′5′-CTTGACGGATGAACTCCTGTCC-3′60.68CD445′-CCAGAAGGAACAGTGGTTTGGC-3′5′-ACTGTCCTCTGGGCTTGGTGTT-3′63.83CFLAR5′-AGTGAGGCGATTTGACCTGCTC-3′5′-CCTCACCAATCTCTGCCATCAG-3′60.75EGR15′-AGCAGCACCTTCAACCCTCAGG-3′5′-GAGTGGTTTGGCTGGGGTAACT-3′62.48IL25′-AGAACTCAAACCTCTGGAGGAAG-3′5′-GCTGTCTCATCAGCATATTCACAC-3′60.03IL45′-CCGTAACAGACATCTTTGCTGCC-3′5′-GAGTGTCCTTCTCATGGTGGCT-3′62.00BAX5′-TCAGGATGCGTCCACCAAGAAG-3′5′-TGTGTCCACGGCGGCAATCATC-3′65.91ITGAV5′-AGGAGAAGGTGCCTACGAAGCT-3′5′-GCACAGGAAAGTCTTGCTAAGGC-3′62.21LAMA15′-GAAGGTGACTGGCTCAGCAAGT-3′5′-AGGCGTCACAACGGAAATCGTG-3′63.89MMP35′-CACTCACAGACCTGACTCGGTT-3′5′-AAGCAGGATCACAGTTGGCTGG-3′63.11NFKB15′-GCAGCACTACTTCTTGACCACC-3′5′-TCTGCTCCTGAGCATTGACGTC-3′62.6PPARG5′-AGCCTGCGAAAGCCTTTTGGTG-3′5′-GGCTTCACATTCAGCAAACCTGG-3′62.71SOD15′-CTCACTCTCAGGAGACCATTGC-3′5′-CCACAAGCCAAACGACTTCCAG-3′62.21TGFB15′-TACCTGAACCCGTGTTGCTCTC-3′5′-GTTGCTGAGGTATCGCCAGGAA-3′62.63TNF5′-CTCTTCTGCCTGCTGCACTTTG-3′5′-ATGGGCTACAGGCTTGTCACTC-3′62.33VCAM15′-GATTCTGTGCCCACAGTAAGGC-3′5′-TGGTCACAGAGCCACCTTCTTG-3′62.45VEGFA5′-TTGCCTTGCTGCTCTACCTCCA-3′5′-GATGGCAGTAGCTGCGCTGATA-3′62.79 Table 2The sequence of primers used for monitoring the atherosclerosis pathwayGeneForward primerReverse primerTmAPOA15′-GTGGATGTGCTCAAAGACAGCG-3′5′-GCTTGCTGAAGGTGGAGGTCAC-3′63.64APOB5′-AGAGGACAGAGCCTTGGTGGAT-3′5′-CTGGACAAGGTCATACTCTGCC-3′60.42APOE5′-GGGTCGCTTTTGGGATTACCTG-3′5′-CAACTCCTTCATGGTCTCGTCC-3′60.68BIRC35′-GCTTTTGCTGTGATGGTGGACTC-3′5′-CTTGACGGATGAACTCCTGTCC-3′60.68CD445′-CCAGAAGGAACAGTGGTTTGGC-3′5′-ACTGTCCTCTGGGCTTGGTGTT-3′63.83CFLAR5′-AGTGAGGCGATTTGACCTGCTC-3′5′-CCTCACCAATCTCTGCCATCAG-3′60.75EGR15′-AGCAGCACCTTCAACCCTCAGG-3′5′-GAGTGGTTTGGCTGGGGTAACT-3′62.48IL25′-AGAACTCAAACCTCTGGAGGAAG-3′5′-GCTGTCTCATCAGCATATTCACAC-3′60.03IL45′-CCGTAACAGACATCTTTGCTGCC-3′5′-GAGTGTCCTTCTCATGGTGGCT-3′62.00BAX5′-TCAGGATGCGTCCACCAAGAAG-3′5′-TGTGTCCACGGCGGCAATCATC-3′65.91ITGAV5′-AGGAGAAGGTGCCTACGAAGCT-3′5′-GCACAGGAAAGTCTTGCTAAGGC-3′62.21LAMA15′-GAAGGTGACTGGCTCAGCAAGT-3′5′-AGGCGTCACAACGGAAATCGTG-3′63.89MMP35′-CACTCACAGACCTGACTCGGTT-3′5′-AAGCAGGATCACAGTTGGCTGG-3′63.11NFKB15′-GCAGCACTACTTCTTGACCACC-3′5′-TCTGCTCCTGAGCATTGACGTC-3′62.6PPARG5′-AGCCTGCGAAAGCCTTTTGGTG-3′5′-GGCTTCACATTCAGCAAACCTGG-3′62.71SOD15′-CTCACTCTCAGGAGACCATTGC-3′5′-CCACAAGCCAAACGACTTCCAG-3′62.21TGFB15′-TACCTGAACCCGTGTTGCTCTC-3′5′-GTTGCTGAGGTATCGCCAGGAA-3′62.63TNF5′-CTCTTCTGCCTGCTGCACTTTG-3′5′-ATGGGCTACAGGCTTGTCACTC-3′62.33VCAM15′-GATTCTGTGCCCACAGTAAGGC-3′5′-TGGTCACAGAGCCACCTTCTTG-3′62.45VEGFA5′-TTGCCTTGCTGCTCTACCTCCA-3′5′-GATGGCAGTAGCTGCGCTGATA-3′62.79 The sequence of primers used for monitoring the atherosclerosis pathway Surface plasmon resonance (SPR) assay Here, the SPR method was applied to investigate the possible interaction of PS NP-treated HUVECs with human peripheral blood mononuclear cells (PBMNCs). In this regard, 5 × 105 HUVECs were plated on SPR chips pre-disinfected using 70% EtOH solution. SPR chips were kept under standard conditions to yield a single-cell confluent layer. After that, chips were incubated with PS NPs at doses of 5 and 100 µg/ml for 48 h. In the next step, SPR chips were washed with pre-warmed PBS solution and gently inserted into the instrument (MP-SPR Navi 210 A, BioNavis Ltd) at a fixed angle at 670 nm wavelength at 30 °C. PBMCs were first isolated from freshly collected blood samples from volunteers using Ficoll-Paque solution. To this end, the volunteers were asked to provide informed consent. Samples were transferred in tubes containing 2500 IU heparin, diluted with PBS at a ratio of 1:1, centrifuged at 400 g, and interphase cells were collected. Inside the SPR apparatus, PBS solution containing 1 × 106 PBMNCs was injected over the HUVEC-coated chips for 10 min under a continuous flow rate of 10 µl/min. The affinity and kinetics of the interaction were analyzed by the SPR-Navi software. Evaluation of protein and nucleic acid adsorption on PS NPs To monitor the interaction of proteins with plastic particles in the aqueous phase, the SDS-PAGE electrophoresis technique was used. In this regard, different experimental groups were designed for monitoring the adsorption of serum proteins as follows: Control (100 µg PS NPs), 100 µg/ml PS NPs + 1% FBS, 100 µg/ml PS NPs + 960 ng/ml cDNA, 100 µg/ml PS NPs + 1% FBS + 960 ng/ml cDNA. PS NPs were exposed to cDNA and FBS for 48 h at 37 °C. After that, all samples were ultracentrifuged at 40,000 g for 1 h, and PS NP pellets from each group were mixed with Laemmli buffer, heated at 90 °C for 5 min, and loaded into each lane of a 10% SDS-PAGE gel. The samples were electrophoresed and stained with Coomassie Brilliant Blue R-250 for 20–30 min. To exclude the excessive stain, gels were washed several times with destaining solution containing 1% acetic acid overnight. The blue colored protein bands were visualized and compared in each group with the control PS NPs. To monitor the interaction of cDNA with PS NPs, agarose gel electrophoresis was done with the synthesized cDNA as described in the previous section. Briefly, the agarose gel was prepared by dissolving 0.5 g of agarose powder in 50 ml TBE buffer (1X) and then stained with fluorescent nucleic acid dye (SafeStain). The gel was placed in an electrophoresis tank containing TBE buffer. 10 µl of each sample mixed with 3–4 µl loading buffer was loaded into the wells, and electrophoresis was run for 30 min at ~ 15 V/cm. Bands were visualized under UV illumination using a gel documentation system. Ex ovo toxicity assay Thirty fertile chicken eggs were obtained from the poultry house of Islamic Azad University of Tabriz (Tabriz, Iran), and incubated at 38 °C with ~ 70% relative humidity on stationary shelves in a humidified incubator (Model: EASY-BATOR 1; Iran). Eggs at ten days of incubation were randomly allocated into Control (n = 10), Vehicle (PBS, n = 10), and 40 µg/ml PS NPs (n = 10) groups. To investigate developmental toxicity, a concentration of 40 µg/ml (50 µL/egg; total dose of 2 µg PS NPs per egg) was selected as a sublethal exposure level. PBS and PS NPs were administered into the air sac using sterile syringe needles, followed by sealing with paraffin. All eggs were kept for an additional 7 days, and embryos were monitored daily through candling. On day 17, chicken embryos were harvested from the eggs, and the heart tissues were precisely dissected. The tissue samples were then fixed in 10% formalin solution for further analyses. After paraffin embedding, 4–5 μm thick sections were prepared and stained using hematoxylin and eosin (H & E) solution. For analyzing the internalization of rhodamine B-labeled PS-NPs into cardiac cells, DAPI staining was used to visualize the nuclei in cardiac tissue Sects. 4–5 μm thick sections were carefully prepared from paraffin-embedded cardiac tissue blocks and stained with DAPI solution at a concentration of 1 µg/ml for 5 min. The slides were monitored using fluorescence microscopy (Olympus; Japan). Histopathological evaluation was performed in a blinded manner. Statistical analysis Data were analyzed using GraphPad Prism version 8.0 (GraphPad Software Inc.) by one-way ANOVA and Tukey’s post hoc test. p-values < 0.05 were considered statistically significant. Results PS NPs characteristics The actual size and morphology of PS NPs were analyzed using SEM (Fig. 2A). According to the data, PS NPs exhibited relatively homogeneous, well-rounded shapes with an average size of 69.08 ± 10.68 nm (Fig. 2A). DLS indicated that the hydrodynamic diameter of PS NPs reached 349.8 ± 43.34 nm with a zeta potential value of -11.2 ± 0.8 mV (Fig. 2B and C). The larger size reported by DLS compared to SEM may be because of the dispersion of PS NPs in deionized water, which is associated with a larger hydrodynamic size. Along with these analyses, FTIR analysis confirmed that the plastic composition was identical to that of PS NPs (Fig. 2D). Numerous absorption peaks were observed within the specified wavenumber ranges. The peak that appeared at ~ 3449 cm⁻¹ can be attributed to the O-H bond stretching vibration peak that is likely due to the presence of moisture or residual water solvent molecules. The spectra of PS showed the presence of the C-H group in the wavenumber range of ~ 2850–3026 cm⁻¹ [21]. The in-plane flexural vibration peak of the C-H bond on -CH is observed at ~ 1493 cm⁻¹. Furthermore, absorption peaks at ~ 755 and 696 cm⁻¹, which correlate to C-H out-of-plane bending vibration absorption, imply that the benzene ring contains only one substituent [22]. These features show the successful fabrication of PS NPs using the current synthesis protocol. Fig. 2Characterization of PS NPs. SEM images showed spherical morphologies with a size of 69.08 ± 10.67 nm (A). DLS analysis of PS NPs revealed a mean diameter and zeta potential values of 349.8 ± 43.34 nm (B) and − 11.2 ± 0.8 mV (C), respectively. FTIR analysis confirmed the chemical composition was identical to that of PS NPs at certain wavelengths (D). PS: Polystyrene Characterization of PS NPs. SEM images showed spherical morphologies with a size of 69.08 ± 10.67 nm (A). DLS analysis of PS NPs revealed a mean diameter and zeta potential values of 349.8 ± 43.34 nm (B) and − 11.2 ± 0.8 mV (C), respectively. FTIR analysis confirmed the chemical composition was identical to that of PS NPs at certain wavelengths (D). PS: Polystyrene PS NPs decreased EC’s viability in a dose-dependent manner MTT assay was used to evaluate the in vitro cytotoxic effects of PS NPs on HUVECs after 48 h (Fig. 3). Based on the data, treatment of HUVECs with different doses of PS NPs led to cell cytotoxicity in a dose-dependent manner. Of note, incubation of HUVECs with 5 and 10 µg/ml PS NPs yielded statistically non-significant differences compared to the control group (p > 0.05). While the toxic effects were evident in the groups treated with 20, 50, 100, 200, and 400 µg/ml of PS NPs for 48 h (Fig. 3). The greatest toxic effect was observed in the 400 µg/ml PS NPs group. Although toxicity increased with concentration, there were no statistically significant differences between the 20, 50, 100, 200, and 400 µg/ml groups (p > 0.05). Based on these findings, 5 and 100 µg/ml PS NPs were selected as representative non-toxic and toxic concentrations for further analyses. Fig. 3MTT assay. Monitoring the cytotoxic effect of PS NPs on HUVEC survival rates after 48 h. A significant reduction was observed in the survival rate of HUVECs treated with 20 µg/ml PS NPs and higher doses compared to the control HUVECs (n = 8). One-way ANOVA with Tukey post hoc. ***p < 0.001, and ****p < 0.0001 MTT assay. Monitoring the cytotoxic effect of PS NPs on HUVEC survival rates after 48 h. A significant reduction was observed in the survival rate of HUVECs treated with 20 µg/ml PS NPs and higher doses compared to the control HUVECs (n = 8). One-way ANOVA with Tukey post hoc. ***p < 0.001, and ****p < 0.0001 Serum protein adsorption was achieved on the PS NP surface The existence of serum proteins on the PS NP surface was assessed using the SDS-PAGE electrophoresis method (Fig. 4). Scanning of acrylamide gels revealed visible protein bands in samples containing protein, PS NPs + FBS, and PS NPs + FBS + cDNA. While no protein bands were detected in the PS NPs and PS NPs + cDNA groups (Fig. 4A). These data confirmed the adsorption of serum proteins on PS NPs after 24 h, and incubation with cDNA does not contribute to protein layer formation on the external surface of PS NPs. RT-PCR assay confirmed the lack of adsorbed nucleic acid contents on the surface of PS NPs (Fig. 4B). Fig. 4Evaluation of protein adsorption on the PS NP surface using SDS-PAGE. Data revealed visible protein bands on the 10% SDS-PAGE gel in PS NPs + 1% FBS and PS NPs + 1% FBS + cDNA groups (n = 2) (A). Agarose gel electrophoresis analysis. Data indicated that PS NPs cannot adsorb nucleic acids on their surface after being incubated with cDNA samples or a combination of cDNA and FBS (Control: positive cDNA sample) (B). NPs: Nanoplastics, FBS: Fetal bovine serum Evaluation of protein adsorption on the PS NP surface using SDS-PAGE. Data revealed visible protein bands on the 10% SDS-PAGE gel in PS NPs + 1% FBS and PS NPs + 1% FBS + cDNA groups (n = 2) (A). Agarose gel electrophoresis analysis. Data indicated that PS NPs cannot adsorb nucleic acids on their surface after being incubated with cDNA samples or a combination of cDNA and FBS (Control: positive cDNA sample) (B). NPs: Nanoplastics, FBS: Fetal bovine serum PS NPs can internalize into HUVECs in vitro The cellular uptake of Rhodamine-B labeled PS NPs was quantified by flow cytometry after 48 h (Fig. 5). Data revealed non-significant differences in the percentage of Rhodamine-B+ cells related to the control group (p > 0.05). Compared to the non-treated control group, PS NPs could be taken up into HUVECs, in which 4.4 ± 1.9% of HUVECs were positive after treatment with × µg/ml PS NPs, while these values reached 5.7 ± 2.2% in the 100 µg/ml PS NPs group. Fig. 5Cellular uptake of Rhodamine-B labelled PS NPs using flow cytometry after 48 h (n = 4). Data are expressed as mean ± SD. One-way ANOVA with Tukey post hoc. PS NP: Polystyrene nanoplastic Cellular uptake of Rhodamine-B labelled PS NPs using flow cytometry after 48 h (n = 4). Data are expressed as mean ± SD. One-way ANOVA with Tukey post hoc. PS NP: Polystyrene nanoplastic PS NPs decreased the interaction between immune cells and ECs To monitor the reciprocal physical interaction of PBMNCs with HUVECs, SPR analysis was conducted. To this end, HUVECs were plated on Au sensor slides and allowed to yield a relatively confluent single-cell layer to mimic the luminal surface of vascular structure (Fig. 6A-B). As shown in the SPR sensorgram, HUVEC-PBMC interactions were powerfully influenced by PS NPs incubation in a dose-dependent manner (Fig. 6C). An extensive and consistent resonance signal (black line; RU = ~ 0.010) was observed in the non-treated HUVECs with a relatively strong and continuous interaction (RU signals) between ECs and PBMCs over 5 min. Fig. 6SPR analysis. Monitoring the physical interaction between PBMNCs and PS NP-treated HUVECs (A-D). HUVECs suspension was gently placed on the surface of the gold-coated SPR chips (Au SPR chip; A). Seeding and attachment of HUVECs on Au SPR chip after 24 h (B). A strong and stable interaction was obtained between HUVECs and PBMNCs in the non-treated group (black line). At 5 µg/ml (red line) and 100 µg/ml (blue line), the RU values were reduced to the minimum levels compared to the control cells (C). Structural and numerical changes of HUVECs following incubation with PS NPs after SPR analysis (D). HUVEC: Human umbilical vein endothelial cells, SPR: Surface plasmon resonance, RU: Resonance unit SPR analysis. Monitoring the physical interaction between PBMNCs and PS NP-treated HUVECs (A-D). HUVECs suspension was gently placed on the surface of the gold-coated SPR chips (Au SPR chip; A). Seeding and attachment of HUVECs on Au SPR chip after 24 h (B). A strong and stable interaction was obtained between HUVECs and PBMNCs in the non-treated group (black line). At 5 µg/ml (red line) and 100 µg/ml (blue line), the RU values were reduced to the minimum levels compared to the control cells (C). Structural and numerical changes of HUVECs following incubation with PS NPs after SPR analysis (D). HUVEC: Human umbilical vein endothelial cells, SPR: Surface plasmon resonance, RU: Resonance unit In contrast, treatment with 5 µg/ml PS NPs resulted in a significant decrease in RU (red line; RU = ~ 0.002), indicating a moderate reduction in PBMNC-HUVEC physical interactions. In the group that received 100 µg/ml PS NPs, the RU value dropped to zero (blue line; RU = ~ 0.000), which showed a nearly complete loss of PBMC-HUVEC interactions. To monitor the consistency of results, Au sensor slides were imaged under light microscopy (Fig. 6D). Bright-field images showed that the number of attached HUVECs was reduced by increasing the concentration of PS NPs, with the minimum number of attached HUVECs obtained in the group treated with 100 µg/ml PS NPs. PS NPs influenced autophagy and atherogenesis responses in ECs To assess the effects of 5 and 100 µg/ml PS NPs on autophagy and atherogenesis pathways, the expression of multiple key genes was monitored using a PCR array (Tables 3 and 4, and Fig. 7A-B). Based on the obtained data, the expression of different genes associated with the autophagic response was altered (Table 3; Fig. 7A). Of note, 5 µg/ml PS NPs increased genes expression of ATG5 (2.89-fold), BECN1 (2.32-fold), DRAM2 (3.25-fold), EIF4G1 (3.02-fold), GABARAPL1 (2.67-fold), HGS (3.27-fold), HTT (2.08-fold), MAPK8 (2.80-fold), PIK3CG (2.002-fold), and RPSGKB1 (2.55-fold), while decreasing gene expression of RB1 (-2.36-fold). In contrast, a diverse gene expression pattern occurred in 48-hour incubation of HUVECs with 100 µg/ml PS NPs. Significant upregulation was observed in genes of ATG16L1 (2.89-fold), HSPA8 (4.48-fold), MAPK14 (2.21-fold), and PIK3CG (2.50-fold). Besides, AMBR1 (-2.69-fold), BAD (-2.14-fold), BECN1 (-7.27-fold), CASP8 (-2.35-fold), and TGM2 (-3.27-fold) were down-regulated following treatment with a 100 µg/ml dose. Table 3PCR array analysis of human autophagy signaling pathway in HUVECs exposed to PS NPsGenesValues are normalized to the non-treated HUVECs5 µg/ml PS NPs100 µg/ml PS NPs AMBR1 1.69 -2.69 ATG16L1 0.61 2.89 ATG5 2.89 1.68 ATG9A -0.92-1.13 BAD 1.28 -2.14 BAX 1.50-0.29 BCL2 0.95-0.29 BCL2L1 1.900.61 BECN1 2.32 -7.27 CASP8 0.77 -2.35 CLN3 1.79-1.44 CTSB -1.34-1.57 CTSD 0.60-1.51 DRAM2 3.25 -0.65 EIF4G1 3.02 0.63 GABARAP 1.72-0.70 GABARAPL1 2.67 1.60 HGS 3.27 0.60 HSPA8 1.48 4.48 HTT 2.08 -0.08 MAPK14 -0.11 2.21 MAPK8 2.80 -0.88 PIK3CG 2.002 2.50 PIK3R4 1.79-1.03 RB1 -2.36 1.01 RPSGKB1 2.55 -0.20 SQSTM1 0.39-0.68 TGM2 -1.13 -3.27 Fold-change values were calculated using the 2–∆∆Ct formula. Fold change greater than and less than 2 are indicated in red and blue, respectively (n=3) Table 3PCR array analysis of human autophagy signaling pathway in HUVECs exposed to PS NPsGenesValues are normalized to the non-treated HUVECs5 µg/ml PS NPs100 µg/ml PS NPs AMBR1 1.69 -2.69 ATG16L1 0.61 2.89 ATG5 2.89 1.68 ATG9A -0.92-1.13 BAD 1.28 -2.14 BAX 1.50-0.29 BCL2 0.95-0.29 BCL2L1 1.900.61 BECN1 2.32 -7.27 CASP8 0.77 -2.35 CLN3 1.79-1.44 CTSB -1.34-1.57 CTSD 0.60-1.51 DRAM2 3.25 -0.65 EIF4G1 3.02 0.63 GABARAP 1.72-0.70 GABARAPL1 2.67 1.60 HGS 3.27 0.60 HSPA8 1.48 4.48 HTT 2.08 -0.08 MAPK14 -0.11 2.21 MAPK8 2.80 -0.88 PIK3CG 2.002 2.50 PIK3R4 1.79-1.03 RB1 -2.36 1.01 RPSGKB1 2.55 -0.20 SQSTM1 0.39-0.68 TGM2 -1.13 -3.27 Fold-change values were calculated using the 2–∆∆Ct formula. Fold change greater than and less than 2 are indicated in red and blue, respectively (n=3) PCR array analysis of human autophagy signaling pathway in HUVECs exposed to PS NPs Fold-change values were calculated using the 2–∆∆Ct formula. Fold change greater than and less than 2 are indicated in red and blue, respectively (n=3) Table 4PCR array analysis of human atherogenesis signaling pathway in HUVECs exposed to PS NPsGenesValues are normalized to the non-treated HUVECs5 µg/ml PS NPs100 µg/ml PS NPs APOA1 3.51 2.07 APOB -0.16-1. 60 APOE 0.21-0.15 BIRC3 3.99 1.56 CD44 2.01 2.002 CFLAR 0.700.84 EGR1 1.11 2.04 IL2 -4.64 -4.94 IL4 -1.80 -3.76 BAX 2.89 2.76 ITGAV 0.01-0.99 LAMA1 -0.37-0.16 MMP3 0.05-0.60 NFKB1 -5.15 -4.02 PPARG 1.93 4.08 SOD1 0.880.85 TGFB1 -0.38-0.81 TNF -4.03 -2.23 VCAM1 2.67 2.83 VEGFA 2.63 2.62 Fold-change values were calculated using the 2–∆∆Ct formula. Fold change greater than and less than 2 are indicated in red and blue, respectively (n=3) Table 4PCR array analysis of human atherogenesis signaling pathway in HUVECs exposed to PS NPsGenesValues are normalized to the non-treated HUVECs5 µg/ml PS NPs100 µg/ml PS NPs APOA1 3.51 2.07 APOB -0.16-1. 60 APOE 0.21-0.15 BIRC3 3.99 1.56 CD44 2.01 2.002 CFLAR 0.700.84 EGR1 1.11 2.04 IL2 -4.64 -4.94 IL4 -1.80 -3.76 BAX 2.89 2.76 ITGAV 0.01-0.99 LAMA1 -0.37-0.16 MMP3 0.05-0.60 NFKB1 -5.15 -4.02 PPARG 1.93 4.08 SOD1 0.880.85 TGFB1 -0.38-0.81 TNF -4.03 -2.23 VCAM1 2.67 2.83 VEGFA 2.63 2.62 Fold-change values were calculated using the 2–∆∆Ct formula. Fold change greater than and less than 2 are indicated in red and blue, respectively (n=3) PCR array analysis of human atherogenesis signaling pathway in HUVECs exposed to PS NPs Fold-change values were calculated using the 2–∆∆Ct formula. Fold change greater than and less than 2 are indicated in red and blue, respectively (n=3) Fig. 7Bar charts of gene expression related to autophagy response and atherogenesis in human ECs after treatment with 5 and 100 µg/ml PS NPs for 48 h (A: Autophagy pathway and B: Atherogenesis). Log2 fold changes are related to gene expression. Up-regulation and down-regulation are indicated in red and blue, respectively. NPs: Polystyrene nanoplastics Bar charts of gene expression related to autophagy response and atherogenesis in human ECs after treatment with 5 and 100 µg/ml PS NPs for 48 h (A: Autophagy pathway and B: Atherogenesis). Log2 fold changes are related to gene expression. Up-regulation and down-regulation are indicated in red and blue, respectively. NPs: Polystyrene nanoplastics Along with these changes, 5 and 100 µg/ml PS NPs could activate several atherogenesis-related genes, including APOA1 (3.51- and 2.07-fold), CD44 (~ 2-fold), BAX (2.89 and 2.76-fold), VCAM1 (2.67- and 2.83-fold), and VEGFA (2.63 and 2.62-fold), respectively. However, gene expression of EGR1 (2.04-fold) and PPARG (4.08-fold) was elevated only at 100 µg/ml, and BIRC3 (3.99-fold) at 5 µg/ml PS NPs. Meanwhile, a downregulation was found in genes of IL2 (-4.64 and − 4.94-fold), NFKB1(-5.15 and − 4.02-fold), and TNF (-4.03 and − 2.23-fold) at both doses of PS NPs, and IL4 (-3.76-fold) after treatment with a 100 µg/ml dose (Table 4; Fig. 7B). Based on these findings, PS NPs appear to influence ECs via alterations in atherogenesis-related gene expression in a dose-dependent manner. PS NPs induced histopathological changes in the chicken embryo heart In this study, the hearts of chicken embryos were treated with PS NPs and then histologically examined to determine whether exposure to PS NPs results in myocardial damage (Fig. 8A). Data indicated 30% of embryo mortality in the group that received PS NPs compared to the Control and PBS groups. Using H & E staining, well-organized and tightly packed cardiomyocytes with normal microstructure were evident in the control and PBS-treated groups. Based on the data, the loss of cardiac cell-to-cardiac cell connection with disorganized myofilament arrangements, degenerative changes, interstitial edema, numerous recruited inflammatory cells, and focal hemorragia were evident in the PS NP-treated group. According to these findings, PS NPs can destroy healthy myocardial structure in chicken embryos. To see whether the pathological changes in chicken embryos are closely related to the PS NPs, the presence of rhodamine B-labeled PS NPs was monitored using IF staining (Fig. 8B). Data confirmed the presence of red-fluorescent PS NPs inside the chicken embryo myocardium, indicating the direct toxic effects of these substances in the avian cardiovascular system. Fig. 8H & E staining of chicken embryo hearts (A). Data indicate pathological changes in the myocardial tissue after being exposed to PS NPs. Features such as hemorragia, necrotic changes, edema, loss of cardiac cell integrity, etc. were evident in the presence of PS NPs. Internalization of rhodamine B-labeled PS NPs into cardiac cells of chicken embryos (B; yellow arrows). The nuclei of the cells were stained blue with DAPI, and PS NPs appeared red in the cells by fluorescent microscopy. PS NPs: Polystyrene nanoplastics, PBS: Phosphate-buffered saline H & E staining of chicken embryo hearts (A). Data indicate pathological changes in the myocardial tissue after being exposed to PS NPs. Features such as hemorragia, necrotic changes, edema, loss of cardiac cell integrity, etc. were evident in the presence of PS NPs. Internalization of rhodamine B-labeled PS NPs into cardiac cells of chicken embryos (B; yellow arrows). The nuclei of the cells were stained blue with DAPI, and PS NPs appeared red in the cells by fluorescent microscopy. PS NPs: Polystyrene nanoplastics, PBS: Phosphate-buffered saline Discussion The NP and MP residuals have recently been a major environmental concern on a global scale, causing widespread damage to ecosystems and human health [23]. These particles can enter the bloodstream and accumulate in various organs of the body, especially the cardiovascular system [13]. Numerous studies have reported that NPs can provoke inflammatory responses, pathological changes, and oxidative stress in vascular ECs, contributing to endothelial dysfunction [13, 24, 25]. However, the underlying mechanisms by which NPs affect vascular cell function and cardiac tissue remain largely unclear. Therefore, in the current study, we conducted experimental research to elucidate the molecular pathways underlying PS NPs-induced vascular damage in vitro and ex ovo models. In the present study, data revealed a dose-dependent reduction in HUVECs viability after treatment with PS NPs, particularly at higher doses from 100 to 400 µg/ml. In line with current data, it was shown that amino-functionalized PS NPs have notable cytotoxicity on HUVECs at different concentrations, including 20 µg/ml, with a survival rate of less than 30% compared to the control group [26]. Martín-Pérez et al. found that the putative toxicity of PS NPs is linked to the particle surface features, in which amino-functionalized PS NPs at 100 µg/ml led to a reduction of HUVECs survival rate, coinciding with the accumulation of oxidants inside the cells [27]. Besides, PS NPs can directly alter cell membrane structure, and these parameters are directly linked to the type and surface charge of plastic particles. For instance, PS NPs can fuse with the hydrophobic core of lipid bilayers, forming a network of disentangled, single polymeric chains. The presence of such complexes damages membrane structure and fluidity, ultimately leading to cell death [28, 29]. This interaction also disrupts ion transport, membrane integrity, signal transduction, and cell death [30]. In a biological system, NP surfaces can adsorb biomolecules, mainly proteins, to form a protein corona [31–33]. Here, we indicated the binding of serum proteins, FBS, on the surface of PS NPs under in vitro conditions. This adsorption was qualitatively assessed using SDS-PAGE electrophoresis, and the findings were limited to indicating adsorbed proteins and did not allow for investigation into their specific identity or functional implications. Although the type of proteins was not determined in the present study, the pattern and intensity of the bands, compared to non-FBS samples, may indicate the formation of a protein corona. In this regard, previous data showed that pre-treatment of PS NPs with human plasma caused different patterns of protein adsorption. It was suggested that surface charge parameters of plastic particles determined the composition and number of adsorbed proteins [34]. The evidence shows that protein-NP interaction primarily occurs via weak bonds, including hydrophobic, hydrogen, electrostatic forces, and Van der Waals attraction forces [35]. Protein corona formation can also be influenced by several factors related to NPs, such as shape, size, and chemical composition of the NPs, as well as the medium (such as proteins and other chemicals), the exposure duration, and the ratio of NPs/protein [36]. Moreover, NPs aggregation is highly dependent on the protein’s electrical charge, leading to the formation of diverse corona structures [37]. These structures can present new environmental and biological identities and affect migration dynamics, degradation pathways, cellular internalization, and interaction targets for MNPs [38, 39]. Flow cytometry analysis indicated that fluorescent-labeled PS NPs can be taken up by HUVECs. Previous studies have suggested that their internalization rate is affected by the dose of plastic particles [40]. In the present study, an upward trend in PS NP uptake was observed as the concentration increased without statistical significance. Despite their consistency with previous reports, these findings do not support a dose-dependent uptake under the current experimental setup. One reason for this effect would be related to the fact that PS NPs uptake increased in a saturating fashion with concentration in HUVECs, possibly due to saturation of uptake mechanisms [41]. Lu and colleagues showed that uptake of fluorescent-labeled PS MNPs by HUVECs at 25 µg/ml was only 3.80% [42]. A recent study reported that RAW264.7 cells internalize PS NPs dose-dependently, and higher concentrations (i.e., 100 µg/ml) had greater fluorescence intensity [43]. It has been shown that the human body can be exposed to plastic particles via three main routes of ingestion, inhalation, and skin contact [44]. These particles can traverse physiological barriers in the human body, entering cells via endocytosis or passive penetration [45]. After entering cells, MNPs interfere with intracellular processes and induce toxic effects [46]. According to available evidence, smaller particles can enter the cell more quickly and efficiently than larger particles, indicating that the size of the NPs is also a determining factor in the mechanism and efficiency of their entry [47]. Smaller NPs typically experience higher uptake by cells, but our study lacked DLS characterization in serum-containing media to examine the impact of protein aggregation and corona formation. These factors might partially explain the low uptake observed in HUVECs, although further studies will be needed to confirm this. Plastic particles can interact with blood components and vascular endothelium, and lead to blood coagulation, thrombosis, reduced immune response, and CVDs [13, 48, 49]. SPR analysis revealed that PS NPs had a strong effect on the interaction between HUVECs and PBMNCs. A dose-dependent decrease in intensity and number of cells was observed with increasing PS NPs concentration, i.e., at 100 µg/ml. This effect would be related to the toxic effects of PS NPs on HUVEC survival rate, leading to detachment of these cells from the surface of the SPR glass. PS NPs may affect key surface receptors, thus preventing proper interaction of ICAM-1, VCAM-1, and E-selectin, which mediate the attachment of PBMNCs to HUVECs. However, the disappearance of the resonance signal at 100 µg/ml may not be solely related to the disruption of receptor-mediated endothelial-immune interactions. Microscopically, higher PS NP concentrations resulted in decreased EC survival and attachment. It is therefore likely that the reduced SPR signal may reflect a loss in cell integrity due to the NPs, such as reduced coverage of the cells on the SPR glass and potential cell detachment or destabilization. Furthermore, there is a possibility that incubation of HUVECs with PS NPs for a prolonged period (48 h) resulted in cytoskeletal disruption, membrane instability, and ultimately apoptotic or necrotic cell death, thereby reducing cell viability and adhesion. Therefore, it is assumed that impaired cell-to-cell interactions and reduced surface coverage by ECs contributed to the observed reduction in SPR signals [50]. There is evidence that NPs can cross biological barriers and accumulate in various tissues, disrupting autophagy and other related processes [51]. We noted that PS NPs at a dose of 5 µg/ml could affect the autophagy pathway by up-regulating ATG5, BECN1, DRAM2, GABARAPL1, HGS, and HTT. Nonetheless, at a dose of 100 µg/ml, more specific regulatory genes, including ATG16L1 and HSPA8, were upregulated, suggesting a chronic stress response and cell survival effort. Similarly, Lu and colleagues found that 100 nm PS NPs penetrate and aggregate within ECs cytoplasm, inducing autophagy initiation and autophagosome formation, in addition to impairing autophagic flux level and cell membranes [52]. Besides, PS NPs can activate the ROS/TGF-β1/Smad pathway in the cardiovascular system, leading to autophagy [53]. In this study, other genes involved in the autophagy pathway, such as MAPK14, MAPK8, and PIK3CG, were upregulated following treatment with PS NPs. NPs-induced oxidative stress activates the AMPK/mTOR/ULK1 axis, which can facilitate the formation of autophagosomes. While this response may be protective at low doses, excessive activation can lead to lysosomal dysfunction and cellular stress [51, 54]. Various studies showed that NPs have the potential to cause cardiovascular toxicity through cardiac dysfunction, vascular thrombosis, and myocardial fibrosis [13, 53, 55]. The results revealed that PS NPs increase expression of some genes related to atherogenesis pathways, including VCAM1, VEGFA, BIRC3, CD44, and EGR1, similar to the aforementioned studies [56]. Zhong and colleagues found that PS NPs facilitate migration of SMC into the intima layer and enhance intima thickness and fibrous lesions, which led to the progression of atherosclerosis [57]. The present study also showed that incubation of HUVECs with 5 and 100 µg/ml PS NPs stimulated apoptosis through increased expression of the pro-apoptotic gene (BAX). In line with these findings, Wang et al. reported that ECs treated with polypropylene NPs (500 nm) for 48 h elevated the mRNA levels of Bax and caspase-3, as well as a decrease in Bcl-2 expression in a dose-dependent manner [58]. Previous studies have also shown the ability of PS NPs to stimulate apoptosis in numerous cells [59, 60]. NPs can induce apoptosis by disrupting mitochondrial function and increasing ROS production, ER stress, and DNA damage [54]. Moreover, PS NPs could disrupt redox equilibrium and trigger inflammatory responses to stimulate apoptosis [61]. In this study, PS NPs also decreased the expression of genes related to inflammation, such as NFKB1, TNF, IL2, and IL4. However, previous evidence has reported that MNPs foster inflammatory responses by releasing pro-inflammatory cytokines [58, 62]. It is possible that activation of apoptosis or autophagy in endothelial cells can eliminate some of the primary inflammatory stimuli in the endothelium and vessel wall, leading to a reduction in inflammatory markers and increased plaque stability. Therefore, PS NPs appear to disrupt endothelial dysfunction and develop atherosclerosis through monocyte recruitment to the endothelium, lipid intracellular accumulation, plaque instability, and rupture. Histological analyses of the present study confirmed that 7-day exposure of chicken embryos to PS NPs caused cardiac damage, including interstitial edema, nuclear pyknosis, cardiomyocyte degeneration, focal infiltration of inflammatory cells, localized hyperemia, and myocardial swelling. Further, the accumulation of PS NPs in cardiac tissues was also shown by fluorescent microscopy, with distinct blue nuclei and red fluorescent NPs inside the cells, implying the uptake and deposition of ~ 100 nm PS NPs, followed by tissue damage in the heart. Consistent with these findings, chick embryos exposed to 25 nm PS NPs (particularly 5 mg/ml) were shown to develop a variety of cardiovascular and vascular defects. These abnormalities included excess cardiac jelly, thinned myocardium and epicardium, ventricular septal defect, persistent truncus arteriosus, and supernumerary arteries [63]. Exposure of rats to PS MPs (~ 0.5 μm) clearly resulted in capillary congestion at 5 mg/l, disorganization of myocardial fibers at 50 mg/l, and disruption of mitochondrial structure. Besides, the detection of PS MPs in the cytoplasm of cardiomyocytes at concentrations of 5 and 50 mg/l confirmed their accumulation and direct cytotoxicity on cardiac tissue [64]. Nevertheless, Huang et al. reported that fluorescently labeled PS MPs with sizes ≥ 50 μm were not detected in the heart tissue of 10-week-old mice, suggesting that small particles are translocated into the bloodstream and accumulate in specific tissues [65]. The present study has several limitations that need to be addressed in future experiments. Regarding the in vitro panel, it would be beneficial to perform additional complementary assays to monitor the current mechanistic findings. For instance, it is proposed to use a proteomics approach to accurately comprehend the impact of PS NPs on pathways related to autophagy and atherosclerosis at the protein level. Moreover, further experiments may be needed to study the formation and characterization of the protein corona on PS NPs. It is also essential to characterize these particles in culture media because the corona can alter their physicochemical properties and biological identity. Conclusion Overall, the findings of this study showed that PS NPs dose-dependently induced endothelial dysfunction in ECs and caused histopathological damage in the myocardial tissue of chicken embryos. These toxic effects were mainly mediated through the uptake and accumulation of PS NPs in endothelial and cardiac cells. PS NPs, by dysregulating the expression of some genes of autophagy and atherosclerotic pathways, could affect apoptosis and enhance cell adhesion, and to some extent disrupt cell membrane structure and integrity. Furthermore, PS NPs exhibited a strong effect on the interaction of endothelial-immune cells by altering both the intensity and the number of interacting cells. Therefore, the results emphasize the potential of PS NPs to induce toxicity and cardiovascular risks and highlight the necessity for greater attention to the biological and health consequences of these developing pollutants.